Mission

ICER's mission is to lead innovation in comparative effectiveness research through methods that integrate considerations of clinical benefit and economic value.  Through a unique collaboration with patients, clinicians, manufacturers, insurers and other healthcare stakeholders, ICER develops tools to support patient decisions and medical policy that share the goal of achieving maximum value for every healthcare dollar.

Staff Only

Remember Me
TwitterLinkedinFacebookFeed
ICER process featured at ISPOR workshop

Image

ICER President Steve Pearson (pictured) and Chief Review Officer Dan Ollendorf, as well as Amy Knudsen, Senior Scientist at Massachusetts General Hospital's Institute for Technology Assessment, presented a workshop at the 13th international meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) on the environment for technology assessment in the U.S., the ICER technology appraisal process, and an interactive case study (based on the ICER CT colonography appraisal) allowing workshop attendees to turn appraisal results into coverage policy.